Breakthrough T1D Blog

We’ve received many questions about the COVID-19 vaccination rollout in provinces and territories across Canada, and specifically at what stage people living with type 1 diabetes (T1D) should expect to receive theirs.

On January 15, 2021 Sernova announced that patients in their ongoing clinical trial show persistent islet function and clinically meaningful improvement in glucose control.

January 28, 2021 marks this year’s #BellLetsTalk day. This provides us the opportunity to talk freely and safely about mental health issues, and to raise awareness of the challenges faced by people living with T1D daily – and how JDRF Canada is looking to do more to address mental health in this community.

For years, Rebecca Redmond’s mantra was to “stick to the devil you know” when managing her type 1 diabetes (T1D). That meant injecting herself with insulin numerous times a day, even after developing a phobia of needles, resulting in debilitating anxiety attacks and sometimes even forgoing meals.

Here are the top 2020 JDRF-funded research projects.

With the holiday season quickly approaching, it’s time to start thinking about shopping lists, holiday plans with friends and family members, and how to keep our children active during their time off from school, while adhering to the safety measures influenced by the global pandemic. We’ve provided some helpful tips to help you stay safe and healthy during the holiday season.

JDRF welcomes the authorization of the first COVID-19 vaccine by Health Canada, which we hope will be one of many to be approved in the coming months to address the pandemic. We are grateful for the unprecedented effort by the many research scientists, clinical trial participants, industry partners and government officials who contributed to global efforts to rapidly bring COVID-19 vaccines through the pipeline and to our communities.

Protecting yourself from the virus on top of everyday diabetes management is a lot to deal with.

Fortunately, we are now better equipped with knowledge of how the virus works and how to best protext ourselves from contracting it. And there is hope on the horizon.

To mark November’s National Diabetes Awareness Month, JDRF is excited to announce a new investment of $6 million to support two Canadian research teams as part of the JDRF-CIHR Partnership to Defeat Diabetes to help accelerate development of stem cell-based therapies for type 1 diabetes (T1D).

We invited people affected by type 1 diabetes (T1D) – children, parents and researchers – to share what they wish people knew about what it means to live with this disease. Read on to learn varying perspectives of how T1D affects members of the community every single day.

JDRF is on a mission to continuously improve the quality of life for people living with type 1 diabetes (T1D) and find a cure for T1D. As all JDRF grants are donor funded, more support is needed to push crucial research forward in Canada. And that’s why we’re inviting you to join Beyond Insulin – our new group of supporters dedicated to accelerating research and helping to find new treatments and ultimately a cure for T1D.